These data suggest that mucin 1 and mucin 4 glycoconjugates play crucial roles in benign meningiomas, while in malignant meningiomas, the mucin 1 glycoconjugates are the major contributors. This evidence concerns the gene MUC4 and Anaplastic (Malignant) Meningioma.